Dedifferentiated carcinoma with clear cell carcinoma of the endometrium: A case report
- PMID: 28667682
- DOI: 10.1111/pin.12557
Dedifferentiated carcinoma with clear cell carcinoma of the endometrium: A case report
Abstract
Endometrial dedifferentiated carcinoma consists of a combination of undifferentiated and differentiated carcinomas. To date, clear cell carcinoma components in endometrial dedifferentiated carcinoma have not been reported. We report the first case of endometrial dedifferentiated carcinoma with clear cell carcinoma in a 58-year-old woman. The uterine corpus was completely replaced and enlarged by a heterogeneous mass. The endometrial cut surface showed a yellowish papillary growing mass involving endometrium and deeper myometrium. Microscopically, the three components (endometrioid carcinoma, FIGO grade 1, clear cell carcinoma and undifferentiated carcinoma) were noted with differentiated carcinoma components lining the endometrial cavity, while undifferentiated carcinoma components were identified in deeper endometrium and myometrium. Our histologic diagnosis was supported by the pattern of immunoreactivity. Tumor cells showed loss of expression of MLH1/PMS2 protein and displayed high microsatellite-instability in all three components. Furthermore, all three components including clear cell carcinoma had loss of PTEN and ARID1A expression. Our observations suggest that the three components derived from a monoclonal origin, as the three components had in common specific genetic alterations.
Keywords: clear cell carcinoma; endometrial dedifferentiated carcinoma; genetic alteration; high microsatellite instability.
© 2017 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.
Similar articles
-
High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.Int J Gynecol Pathol. 2019 Jan;38 Suppl 1(Iss 1 Suppl 1):S40-S63. doi: 10.1097/PGP.0000000000000491. Int J Gynecol Pathol. 2019. PMID: 30550483 Free PMC article. Review.
-
Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study.Hum Pathol. 2018 Feb;72:100-106. doi: 10.1016/j.humpath.2017.11.006. Epub 2017 Nov 11. Hum Pathol. 2018. PMID: 29133142
-
Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features.Adv Anat Pathol. 2011 Nov;18(6):415-37. doi: 10.1097/PAP.0b013e318234ab18. Adv Anat Pathol. 2011. PMID: 21993268 Review.
-
Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.Am J Surg Pathol. 2009 Dec;33(12):1869-77. doi: 10.1097/PAS.0b013e3181bc9866. Am J Surg Pathol. 2009. PMID: 19898223
-
Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.Cancer Res. 2000 Dec 15;60(24):7052-6. Cancer Res. 2000. PMID: 11156411
Cited by
-
Dedifferentiated endometrial carcinoma arising from serous carcinoma: Diagnostic challenges and recommendations.Gynecol Oncol Rep. 2023 Apr 13;47:101188. doi: 10.1016/j.gore.2023.101188. eCollection 2023 Jun. Gynecol Oncol Rep. 2023. PMID: 37122437 Free PMC article.
-
[Un- and dedifferentiated endometrial carcinoma : A rare entity with a wide range of differential diagnosis].Pathologe. 2019 Nov;40(6):609-618. doi: 10.1007/s00292-019-00670-1. Pathologe. 2019. PMID: 31578630 Review. German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
